Search
for
Sort by
Research 571–600 of 1000+
- TGFβ and cancer metastasis: an inflammation link
- Targeting Wnt Signaling for Gastrointestinal Cancer Therapy: Present and Evolving Views
- Transglutaminase-3, an esophageal cancer-related gene
- Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022
- Male pattern baldness and prostate cancer risk in a population-based case–control study
- Emerging Roles for Ion Channels in Ovarian Cancer: Pathomechanisms and Pharmacological Treatment
- Long-term use of 5α-reductase inhibitors and the risk of male breast cancer
- Relationship of Early-Onset Baldness to Prostate Cancer in African-American Men
- The Enigma of the Stigma of Hair Loss: Why is Cancer-Treatment Related Alopecia so Traumatic for Women?
- Epigenetic regulation in adult stem cells and cancers
- Rare Germline Pathogenic Variants Identified by Multigene Panel Testing and the Risk of Aggressive Prostate Cancer
- Age-Dependent Associations between Androgenetic Alopecia and Prostate Cancer Risk
- Cellular heterogeneity and microenvironmental control of skin cancer
- Cancer risk in patients with alopecia areata: a nationwide population‐based matched cohort study
- The evolution of primary multimodality treatment in resectable breast cancer
- Androgenetic alopecia at various ages and prostate cancer risk in an equal-access multiethnic case–control series of veterans
- Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective
- Spironolactone, a Classic Potassium-Sparing Diuretic, Reduces Survivin Expression and Chemosensitizes Cancer Cells to Non-DNA-Damaging Anticancer Drugs
- Cancer risk by the subtype of alopecia
- Gemcitabine in combination with vinorelbine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancer
- A Phase II Study of Vaginal Testosterone Cream (TEST) vs. Estring for Vaginal Dryness or Decreased Libido in Women with Early Stage Breast Cancer (BC) Treated with Aromatase Inhibitors (AIs).
- Understanding the role of sex hormones in cancer for the transgender community
- The Comparative Safety of Epirubicin and Cyclophosphamide versus Docetaxel and Cyclophosphamide in Lymph Node-Negative, HR-Positive, HER2-Negative Breast Cancer (ELEGANT): A Randomized Trial
- Estrogen deprivation effects of endocrine therapy in breast cancer patients: Incidence, management and outcome
- Finasteride Use and Risk of Male Breast Cancer: A Case–Control Study Using Individual-Level Registry Data from Denmark, Finland, and Sweden
- lncRNAs UC.145 and PRKG1-AS1 Determine the Functional Output of DKK1 in Regulating the Wnt Signaling Pathway in Gastric Cancer
- Prolonged remissions of metastatic breast cancer achieved with a six-drug regimen of relatively low toxicity
- Small cell lung cancer: Results of a phase II study of 1,2,4 triglycidylurazol
- Redefining the “crown”: Approaching chemotherapy‐induced alopecia among Black patients with breast cancer
- Chemotherapy-Induced Alopecia in Ovarian Cancer: Incidence, Mechanisms, and Impact Across Treatment Regimens